Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 109, Issue 12, 5136-5142, June 15, 2007
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801
Blood DeAngelo et al. 109: 5136

Supplemental materials for: DeAngelo et al, Vol 109, Issue 12, 5136-5142

The following CALGB member institutions and investigators participated in this study and were supported by the indicated National Cancer Institute grants:

Dana Farber-Partners, Boston, MA – Eric P. Winer, M.D., supported by CA32291
Duke University Medical Center, Durham, NC – Jeffrey Crawford, M.D., supported by CA47577
Nevada Cancer Research Foundation Community Clinical Oncology Program, Las Vegas, NV – John Ellerton, M.D., supported by CA35421
University of Chicago, IL – Gini Fleming, M.D., supported by CA41287
University of Iowa, Iowa City, IA – Gerald Clamon, MD, supported by CA47642
University of North Carolina at Chapel Hill, NC – Thomas C. Shea, M.D., supported by CA47559
University of Maryland Greenebaum Cancer Center, Baltimore, MD – Martin Edelman, M.D., supported by CA31983
University of Missouri/Ellis Fischel Cancer Center, Columbia, MO – Michael C Perry, M.D., supported by CA12046
University of Nebraska Medical Center, Omaha, NE – Anne Kessinger, M.D., supported by CA77298
University of California at San Diego, CA – Joanne Mortimer, M.D., supported by CA11789
University of California at San Francisco, CA – Alan P. Venook, M.D., supported by CA60138
Wake Forest University School of Medicine, Winston-Salem, NC – David D Hurd, M.D., supported by CA03927
Walter Reed Army Medical Center, Washington, DC – Thomas Reid, M.D., supported by CA26806
Weill Medical College of Cornell University, New York, NY – Scott Wadler, M.D., supported by CA07968

The following SWOG member institutions participated in this study:

City of Hope Medical Center, Duarte, CA
Columbus Community Clinical Oncology Program, OH
Loyola University
Oregon Health Sciences Center, Portland OR
South Alabama Community Clinical Oncology Program, mobile, AL
Stanford University, Palo Alto, CA
University of Arizona, Tucson, AZ
University of New Mexico, Albuquerque, NM
University of Washington, Seattle. WA
Wichita Community Clinical Oncology Program, KS.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020